Last updated: May 6, 2025
Sponsor: Sensydia Corporation
Overall Status: Active - Recruiting
Phase
N/A
Condition
Vascular Diseases
Treatment
Cardiac Performance System (CPS)
Clinical Study ID
NCT06870591
CPS_PIVOTAL
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Adults aged 18 years or older
Scheduled for clinically indicated right heart catheterization
Ability to provide informed consent
Exclusion
Exclusion Criteria:
Heart transplant recipients
Patients with a left ventricular assist device (LVAD)
Presence of external devices (e.g., Holter monitors) or surgical scars/wounds thatinterfere with CPS measurements
Measurement concerns related to data reliability or quality
Study Design
Total Participants: 600
Treatment Group(s): 1
Primary Treatment: Cardiac Performance System (CPS)
Phase:
Study Start date:
April 22, 2025
Estimated Completion Date:
September 30, 2026
Study Description
Connect with a study center
Huntsville Hospital Heart Center
Huntsville, Alabama 35801
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.